PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Sleepers made from recycled plastic could make railways even more eco-friendly

Railway sleepers produced from selected recycled plastics are just as strong and could save thousands of tons of emissions and, shows study

2024-12-12
(Press-News.org) Railways, the most climate-friendly mode of transport bar long-distance buses, are bound to play an important role in the fight for net zero. The total emissions of railway travel are currently 31 grams of CO2 equivalents (CO2e) per passenger kilometer, half the amount as for the most economical electrical vehicles.

But the carbon emissions of railway traffic can be further reduced, shows a new study in Frontiers in Sustainability by authors in Finland. This is because typical construction materials such as steel and concrete are energetically costly to produce, transport, handle, and maintain. Even on the busiest train lines, these costs amount to 30% of total emissions, and this percentage increases sharply as the traffic volume decreases.

“Here we show that recycled plastics could be used as the material for railway sleepers and that overall emissions would be reduced. A smaller carbon footprint is achieved when currently incinerated waste streams are used as material,” said Dr Heikki Luomala, the study’s first author and a project manager at Tampere University.

“We estimate that the CO2 reduction by repulping the available waste stream in Finland could amount to the heating emissions of 1,200 households, that is 3,610 tCO2e (tons of CO2 equivalents) per year.”

Two types of plastic tested

Luomala and colleagues studied the feasibility and GHG emission savings resulting from gradually phasing out the wooden and concrete railway sleepers in Finland and replacing them with recycled plastic. The lifespan of a sleeper is between 10 to 60 years and decreases with increasing traffic intensity, due to mechanical damage.

An important source of plastic waste is the packaging sector, which uses up approximately 40% of the total plastic production. Within this industry, so-called liquid packaging board (LPB) – a mix of polyethylene, polypropylene, ethylene vinyl alcohol, and polyethylene terephthalate – is the fastest growing product. Another important source of plastic waste is electronic and electrical equipment, accounting for approximately 6% of total plastic usage. Its main plastic component is acrylonitrile butadiene styrene (ABS).

In the past, plastic waste was often exported from Finland to the Far East, but in recent years the ‘ALL-IN for Plastics Recycling’ (PLASTin) initiative was launched to make Finland a leader in plastic recycling.

Luomala et al. produced specimens of railway sleepers (0.15m thick, 0.25m wide, and 2.6m long) made from LPB and ABS and subjected these to a battery of mechanical tests. Their intent was to test if the prototypes confirmed to international standards for the plastic and railway industries.

Implementation in the real world is on track

Specimens made from both types of plastic passed the strength and bending tests. But only recycled ABS was able to withstand the maximum tested temperature of 55°C without significant softening during hot summers.

“Recycled ABS is much more suitable as railway sleeper material than recycled LPB: the strength and stiffness properties of ABS are approximately three times higher and closer to that of wooden sleepers,” said Luomala.

Plastic railway sleepers offer several advantages, for example easy formability, low cost, light weight, and resistance to environmental conditions. The use of recycled plastic also allows greater design flexibility for sleeper shape.

The Finnish Transport Infrastructure Agency has already shown interest in the study’s findings.

“When it comes to the implementation of recycled ABS for use as railway sleepers, further tests should first be conducted at full scale. Their long-term behavior, for example in terms like UV resistance, should also be tested,” warned Luomala.

END


ELSE PRESS RELEASES FROM THIS DATE:

Ugh, my stomach: Identifying amino acids that prevent sporulation in food poisoning

Ugh, my stomach: Identifying amino acids that prevent sporulation in food poisoning
2024-12-12
Food poisoning is a common, yet unpleasant, illness caused by eating contaminated items. It is sometimes caused by Clostridium perfringens, a pathogen widely found in soil and the intestinal tracts of animals. The pathogen multiplies in environments with little oxygen, for example, curry stored in a pot. After ingestion of the pathogen, they form spores in the small intestinal tracts. The toxins produced during spore formation cause diarrhea and abdominal pain, but the underlying mechanism of spore formation has not been fully understood. Associate Professor Mayo Yasugi’s team at Osaka Metropolitan University’s ...

Air pollution in India linked to millions of deaths

Air pollution in India linked to millions of deaths
2024-12-12
A new study from Karolinska Institutet shows that long-term exposure to air pollution contributes to millions of deaths in India. The research, published in The Lancet Planetary Health, emphasises the need for stricter air quality regulations in the country. Air pollution consisting of particles smaller than 2.5 micrometres in diameter, PM2.5, can enter the lungs and bloodstream and is a major health risk in India. Researchers have now examined the link between these particles and mortality over a ten-year ...

Study finds widening inequalities in child vaccination rates across England

2024-12-12
Inequalities in childhood vaccination are widening in England, with uptake rates of five key vaccines consistently lower in young children living in areas of higher deprivation from 2019 to 2023, finds a study published by The BMJ today.  The researchers say vaccine uptake was below the World Health Organization’s recommended 95% target for all vaccinations studied and call for urgent action to strengthen systems for childhood vaccination. Protecting children from vaccine preventable diseases ...

Investigation raises new concerns over landmark trial for top selling anti-platelet drug

2024-12-12
An investigation published by The BMJ today raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval for the anti-platelet drug ticagrelor (Brilinta in the US and Brilique in Europe), manufactured by AstraZeneca. Peter Doshi, senior editor at The BMJ, reveals new details that show problems in data reporting after obtaining primary PLATO trial records and unpublished data through a freedom of information request. The PLATO trial was published in the New England Journal of Medicine (NEJM) in 2009. Assessing over 18,000 patients in 43 countries, investigators reported that ticagrelor ...

Making chemotherapy for Hodgkin lymphoma kinder to patients

Making chemotherapy for Hodgkin lymphoma kinder to patients
2024-12-12
A simple change to the chemotherapy regimen for people with Hodgkin lymphoma could reduce the long-term health impacts that can result from treatment, according to researchers in Cambridge. The findings could lead to the national guidance on chemotherapy treatment for these patients being revised. The study, published today in The Lancet Oncology was led by Cambridge University Hospitals NHS Foundation Trust (CUH) and the Wellcome Sanger Institute. It compares the lasting effects of two chemotherapy regimens used to treat Hodgkin lymphoma in younger adults. Hodgkin lymphoma ...

ACS study finds early-onset colorectal cancer cases surge globally

ACS study finds early-onset colorectal cancer cases surge globally
2024-12-12
ATLANTA, December 11, 2024 — A new study led by American Cancer Society (ACS) researchers shows that early-onset colorectal cancer (CRC) incidence rates are rising in 27 of 50 countries/territories worldwide, 20 of which have either exclusive or faster increases for early-onset disease. In 14 countries, including the United States, rates are increasing in young adults while stabilizing in those 50 years and older. The research is published today in the journal The Lancet Oncology. “The ...

Fluctuating blood pressure tied to problems with thinking skills

2024-12-11
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, DECEMBER 11, 2024 MINNEAPOLIS – Older adults whose blood pressure fluctuates over time may be more likely to have problems with thinking and memory skills, according to a study published in the December 11, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The association was found in Black participants but not in white participants in the study.   The study does not prove that fluctuations in blood pressure cause problems with thinking skills; it only shows an association. “These results suggest ...

Scientists find promising new target for antidepressants—in the gut

2024-12-11
Researchers have discovered new connections between the gut and brain that hold promise for more targeted treatments for depression and anxiety, and could help prevent digestive issues in children by limiting the transmission of antidepressants during pregnancy.  The study, published in the journal Gastroenterology, shows that increasing serotonin in the gut epithelium—the thin layer of cells lining the small and large intestines—improves symptoms of anxiety and depression in animal studies. The researchers also found ...

Antidepressants may act in gut to reduce depression and anxiety

2024-12-11
NEW YORK, NY (Dec. 11, 2024)--Most of us have experienced the effects of moods and emotions on our gastrointestinal tract, from “butterflies” in the stomach caused by nervousness to a loss of appetite when we’re feeling blue. A new study in animals suggests that targeting antidepressant medications to cells in the gut could not only be an effective treatment of mood disorders like depression and anxiety but may also cause fewer cognitive, gastrointestinal, and behavioral side effects for patients and their children than current treatments. “Antidepressants like Prozac and Zoloft that raise serotonin levels are important first-line ...

New PROSPECT-lung trial launches to advance treatment options for operable non-small cell lung cancer

2024-12-11
The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung cancer. The trial, which is the first to open through the newly formed National Cancer Institute (NCI) Clinical Trials Innovation Unit (CTIU), aims to evaluate the role of immunotherapy before and after surgery in patients with non-small cell lung cancer. The PROSPECT-Lung trial is a large, multicenter trial developed and led by the Alliance for Clinical Trials in Oncology and the SWOG Cancer Research Network and conducted within the NIH-funded NCI National Clinical Trials Network (NCTN), ...

LAST 30 PRESS RELEASES:

Sleepers made from recycled plastic could make railways even more eco-friendly

Ugh, my stomach: Identifying amino acids that prevent sporulation in food poisoning

Air pollution in India linked to millions of deaths

Study finds widening inequalities in child vaccination rates across England

Investigation raises new concerns over landmark trial for top selling anti-platelet drug

Making chemotherapy for Hodgkin lymphoma kinder to patients

ACS study finds early-onset colorectal cancer cases surge globally

Fluctuating blood pressure tied to problems with thinking skills

Scientists find promising new target for antidepressants—in the gut

Antidepressants may act in gut to reduce depression and anxiety

New PROSPECT-lung trial launches to advance treatment options for operable non-small cell lung cancer

The Welch Foundation honors Rice’s Wang for pioneering contributions to sustainable energy solutions

Hospital payment caps could save millions of dollars for state employee health plans

Intraarterial radionuclide therapy safe and effective for advanced meningioma patients

University of Tennessee and Sheffield sign MOU to facilitate collaborations

Nemours Children’s Health Initiative to start HPV vaccination at age 9 improved completion rates

Nova SBE and New York University Tandon School of Engineering launch transatlantic dual degree program

2025 SPIE-Franz Hillenkamp Postdoctoral Fellowship awarded to Morgan Fogarty

Grants expand roadway safety programs to Native American youth and older drivers

Database documents sex differences in cancer biology, risk, and treatment

University of Virginia's Silvia Blemker recognized by NAI for advancing muscle health through innovation

New study provides a picture of preconception health across three generations in the UK

US veterans report average happiness levels of 5.41 out of 7, with greater happiness most associated with reporting greater purpose in life, lower depressive symptoms, and higher optimism, emotional s

Tattoo or not tattoo: Testing the limits of beauty in body art

New study reveals unique insights into the life and death of Stone Age individuals from modern-day Ukraine

Feeling itchy? Study suggests novel way to treat inflammatory skin conditions

Caltech creates minuscule robots for targeted drug delivery

Noninvasive imaging method can penetrate deeper into living tissue

Researchers discover zip code that allows proteins to hitch a ride around the body

The distinct nerve wiring of human memory

[Press-News.org] Sleepers made from recycled plastic could make railways even more eco-friendly
Railway sleepers produced from selected recycled plastics are just as strong and could save thousands of tons of emissions and, shows study